(c) 2024 PillSync.com

Naproxen Naproxen 500 MG Oral Tablet

1 INDICATIONS AND USAGE Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea Naproxen tablets and naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: • rheumatoid arthritis • osteoarthritis • ankylosing spondylitis • polyarticular juvenile idiopathic arthritis Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: • tendonitis • bursitis • acute gout the management of: • pain • primary dysmenorrhea

Glenmark Generics Inc., USA


6 years ago OVAL ORANGE G 32 500 Naproxen  Naproxen 500 MG Oral Tablet

OVAL ORANGE G 32 500

6 years ago OVAL ORANGE G 32 500 Naproxen  Naproxen 500 MG Oral Tablet

G 32 500 OVAL ORANGE

16 HOW SUPPLIED/STORAGE AND HANDLING Naproxen Tablets, USP 250 mg: circular, light orange colored, flat, uncoated tablets, engraved with ‘G’ and ‘32’ on either side of a break line on one side and ‘250’ on the other side. Packaged in light-resistant bottles of 100 and 500. Bottles of 100, NDC 68462-188-01 Bottles of 500, NDC 68462-188-05 Naproxen Tablets, USP 375 mg: oval, light orange colored, biconvex, uncoated tablets, engraved with ‘G 32’ on one side and ‘375’ on the other side. Packaged in light-resistant bottles of 100 and 500. Bottles of 100, NDC 68462-189-01 Bottles of 500, NDC 68462-189-05 Naproxen Tablets, USP 500 mg: capsule shaped, light orange colored, uncoated tablets, debossed with ‘G’ and ‘32’ on either side of a break line on one side and ‘500’ on the other side. Packaged in light-resistant bottles of 30, 50, 100 and 500. Bottles of 30, NDC 68462-190-30 Bottles of 50, NDC 68462-190-50 Bottles of 100, NDC 68462-190-01 Bottles of 500, NDC 68462-190-05 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in well-closed containers.

NAPROXEN SODIUM Tablets, USP 275 mg: blue, oval, film-coated tablets with ‘G 0’ engraved on one side and ‘275’ on the other side. Packaged in bottles of 100 and 500. Bottles of 100, NDC 68462-178-01 Bottles of 500, NDC 68462-178-05

NAPROXEN SODIUM Tablets, USP 550 mg: blue colored, modified capsule shaped, biconvex, film-coated tablets, engraved with ‘G’ and ‘0’ on either side of a break line and a break line on the other side. Packaged in bottles of 100 and 500. Bottles of 100, NDC 68462-179-01 Bottles of 500, NDC 68462-179-05 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in well-closed containers.


More pills like OVAL G 32 500

Related Pills

naproxen tablet naproxen sodium tablet

glenmark pharmaceuticals limited inc., usa

Naproxen 500 MG Oral Tablet

Glenmark Pharmaceuticals Limited Inc., USA

naproxen tablet naproxen sodium tablet

glenmark pharmaceuticals limited inc., usa

Naproxen 250 MG Oral Tablet

Glenmark Pharmaceuticals Inc., USA

naproxen tablet naproxen sodium tablet

glenmark pharmaceuticals limited inc., usa

Naproxen Naproxen 500 MG Oral Tablet

Glenmark Generics Inc., USA

Naproxen 500 MG Oral Tablet

Glenmark Generics Inc., USA












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site